3.5. Chiglitazar Pretreatment Ameliorates Sepsis-Induced Metabolic Dysregulation via Activation of the SIRT1/PGC-1α/PPARα/GPAT3 Signaling Axis. This evidence concerns the gene PPARGC1A and Sepsis.